Meanwhile, the study of Reindl-Schwaighofer et al., reported a significantly lower plasma ACE activity, measured as angiotensin II/I ratio, related to severe COVID-19, and that did not correlate with ACE concentrations in plasma [30]. This evidence concerns the gene AGT and COVID-19.